Thermo Fisher Scientific Stock-Based Comp decreased by 1.2% to $83.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.7%, from $75.00M to $83.00M. Over 4 years (FY 2021 to FY 2025), Stock-Based Comp shows an upward trend with a 7.7% CAGR.
An increase may signal a strategy to preserve cash or align employee interests with shareholders, but it also results in share dilution.
Stock-based compensation is a non-cash expense where employees and executives are rewarded with equity or stock options...
High-growth technology firms often have higher stock-based compensation as a percentage of revenue compared to mature industrial firms.
stock_based_compensation| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $51.00M | $51.00M | $77.00M | $78.00M | $77.00M | $77.00M | $75.00M | $76.00M | $74.00M | $67.00M | $61.00M | $70.00M | $84.00M | $68.00M | $79.00M | $75.00M | $81.00M | $70.00M | $84.00M | $83.00M |
| QoQ Change | — | +0.0% | +51.0% | +1.3% | -1.3% | +0.0% | -2.6% | +1.3% | -2.6% | -9.5% | -9.0% | +14.8% | +20.0% | -19.0% | +16.2% | -5.1% | +8.0% | -13.6% | +20.0% | -1.2% |
| YoY Change | — | — | — | — | +51.0% | +51.0% | -2.6% | -2.6% | -3.9% | -13.0% | -18.7% | -7.9% | +13.5% | +1.5% | +29.5% | +7.1% | -3.6% | +2.9% | +6.3% | +10.7% |